Literature DB >> 14606043

Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35.

Albena Jordanova1, Florian P Thomas, Velina Guergueltcheva, Ivailo Tournev, Francisco A A Gondim, Borjana Ishpekova, Els De Vriendt, An Jacobs, Ivan Litvinenko, Neviana Ivanova, Borjan Buzhov, Peter De Jonghe, Ivo Kremensky, Vincent Timmerman.   

Abstract

Dominant intermediate Charcot-Marie-Tooth (DI-CMT) neuropathy is a genetic and phenotypic variant of classical CMT, characterized by intermediate nerve conduction velocities and histological evidence of both axonal and demyelinating features. We report two unrelated families with intermediate CMT linked to a novel locus on chromosome 1p34-p35 (DI-CMTC). The combined haplotype analysis in both families localized the DI-CMTC gene within a 6.3-cM linkage interval flanked by markers D1S2787 and D1S2830. The functional and positional candidate genes, Syndecan 3 (SDC3), and lysosomal-associated multispanning membrane protein 5 (LAPTM5) were excluded for pathogenic mutations.

Entities:  

Mesh:

Year:  2003        PMID: 14606043      PMCID: PMC1180404          DOI: 10.1086/379792

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

2.  Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24.

Authors:  L Kalaydjieva; J Hallmayer; D Chandler; A Savov; A Nikolova; D Angelicheva; R H King; B Ishpekova; K Honeyman; F Calafell; A Shmarov; J Petrova; I Turnev; A Hristova; M Moskov; S Stancheva; I Petkova; A H Bittles; V Georgieva; L Middleton; P K Thomas
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

3.  LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells.

Authors:  C N Adra; S Zhu; J L Ko; J C Guillemot; A M Cuervo; H Kobayashi; T Horiuchi; J M Lelias; J D Rowley; B Lim
Journal:  Genomics       Date:  1996-07-15       Impact factor: 5.736

Review 4.  N-syndecan: structure and function of a transmembrane heparan sulfate proteoglycan.

Authors:  D J Carey
Journal:  Perspect Dev Neurobiol       Date:  1996

5.  Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D).

Authors:  V Ionasescu; C Searby; V C Sheffield; T Roklina; D Nishimura; R Ionasescu
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

6.  Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A.

Authors:  M Saito; Y Hayashi; T Suzuki; H Tanaka; I Hozumi; S Tsuji
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

7.  Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies.

Authors:  L E Warner; P Mancias; I J Butler; C M McDonald; L Keppen; K G Koob; J R Lupski
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

8.  Mutation of the myelin P0 gene in Charcot-Marie-tooth neuropathy type 1.

Authors:  K Hayasaka; A Ohnishi; G Takada; Y Fukushima; Y Murai
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

9.  Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity.

Authors:  K Ben Othmane; L T Middleton; L J Loprest; K M Wilkinson; F Lennon; M P Rozear; J M Stajich; P C Gaskell; A D Roses; M A Pericak-Vance
Journal:  Genomics       Date:  1993-08       Impact factor: 5.736

10.  Connexin mutations in X-linked Charcot-Marie-Tooth disease.

Authors:  J Bergoffen; S S Scherer; S Wang; M O Scott; L J Bone; D L Paul; K Chen; M W Lensch; P F Chance; K H Fischbeck
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

View more
  19 in total

Review 1.  Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.

Authors:  Kinga Szigeti; Eva Nelis; James R Lupski
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.

Authors:  Stephanie N Oprescu; Laurie B Griffin; Asim A Beg; Anthony Antonellis
Journal:  Methods       Date:  2016-11-20       Impact factor: 3.608

Review 3.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.

Authors:  Garth Nicholson; Simon Myers
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Crystallization and preliminary X-ray analysis of a native human tRNA synthetase whose allelic variants are associated with Charcot-Marie-Tooth disease.

Authors:  Wei Xie; Paul Schimmel; Xiang-Lei Yang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-30

Review 6.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

7.  Clinical, neurophysiological and morphological study of dominant intermediate Charcot-Marie-Tooth type C neuropathy.

Authors:  Florian P Thomas; Velina Guergueltcheva; Francisco A A Gondim; Ivailo Tournev; Chitharanjan V Rao; Boryana Ishpekova; Laurence J Kinsella; Yi Pan; Thomas J Geller; Ivan Litvinenko; Peter De Jonghe; Steven S Scherer; Albena Jordanova
Journal:  J Neurol       Date:  2016-01-02       Impact factor: 4.849

Review 8.  tRNA Metabolism and Neurodevelopmental Disorders.

Authors:  Ashleigh E Schaffer; Otis Pinkard; Jeffery M Coller
Journal:  Annu Rev Genomics Hum Genet       Date:  2019-05-13       Impact factor: 8.929

9.  Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models.

Authors:  Alejandro Leal; Kathrin Huehne; Finn Bauer; Heinrich Sticht; Philipp Berger; Ueli Suter; Bernal Morera; Gerardo Del Valle; James R Lupski; Arif Ekici; Francesca Pasutto; Sabine Endele; Ramiro Barrantes; Corinna Berghoff; Martin Berghoff; Bernhard Neundörfer; Dieter Heuss; Thomas Dorn; Peter Young; Lisa Santolin; Thomas Uhlmann; Michael Meisterernst; Michael Werner Sereda; Michael Sereda; Ruth Martha Stassart; Gerd Meyer zu Horste; Klaus-Armin Nave; André Reis; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2009-03-17       Impact factor: 2.660

10.  Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant.

Authors:  Kenji Tanabe; Kohji Takei
Journal:  J Cell Biol       Date:  2009-06-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.